AeroLeads people directory · profile

Robert Levak Email & Phone Number

Business Owner at Phoenix Molecular Designs
Location: North Vancouver, British Columbia, Canada 18 work roles 8 schools
1 work email found @charter.net 5 phones found area 425 and 206 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 5 phones

Work email r****@charter.net
Direct phone (425) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Business Owner
Location
North Vancouver, British Columbia, Canada

Who is Robert Levak? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Robert Levak is listed as Business Owner at Phoenix Molecular Designs, based in North Vancouver, British Columbia, Canada. AeroLeads shows a work email signal at charter.net, phone signal with area code 425, 206, and a matched LinkedIn profile for Robert Levak.

Robert Levak previously worked as Business Owner at Levak Oncostrategy Consulting Sole Proprietorship and Board Member at Phoenix Molecular Designs. Robert Levak holds Certificate, Corporate Governance from Kellogg Executive Education.

Company email context

Email format at Phoenix Molecular Designs

This section adds company-level context without repeating Robert Levak's masked contact details.

rlevak@charter.net
76% confidence

AeroLeads found 1 current-domain work email signal for Robert Levak. Compare company email patterns before reaching out.

Profile bio

About Robert Levak

• Over 25 years of experience in oncology with over 20 years in biotech strategy and commercialization including corporate strategy, early-stage pipeline commercial strategy, asset development strategy, in-line marketing, sales and sales management diagnostic and competitive strategy.• Proven leadership at Seattle Genetics and at Genentech. -Global Marketing Lead, Tukysa®, ladiratuzumab vedotin; Commercial Core Team Lead (SGN-CD19, SGN-CD40, SGN-CD75); Commercial lead driving the Cascadian acquisition and Immunomedics licensing deal; Pathology team lead for Adcetris® sales; Non-promotional marketing lead, Adcetris®. -Commercial Team Leader (CTL) on several Genentech core teams including Perjeta® and Kadcyla®.• Ability to collaborate and build strong relationships with key stakeholders in development, regulatory, research and safety organizations. Have presented to and garnered support for strategic recommendations from Sr. Leadership.• Highly accountable for results, commitment to execution and innovative marketing approaches.• Proven track record including 2015 & 2018 CEO Award at Seattle Genetics. Yearly Marketing Excellence awards in 2007, 2008 & 2009 at Genentech.

Listed skills include Oncology, Clinical Trials, Clinical Development, Biotechnology, and 21 others.

Current workplace

Robert Levak's current company

Company context helps verify the profile and gives searchers a useful next step.

Phoenix Molecular Designs
Phoenix Molecular Designs
Business Owner
AeroLeads page
18 roles

Robert Levak work experience

A career timeline built from the work history available for this profile.

Business Owner

Current
Levak Oncostrategy Consulting Sole Proprietorship

Strategy consulting services for development and commercialization of oncology assets from pre-IND through product launch in US and global markets including life-cycle value maximization.

Mar 2022 - Present

Head, Global Marketing Oncology

Vancouver, Bc, Ca

Apr 2021 - Feb 2022

Division Sales Manager - Tukysa

Bothell, Washington, Us

Dec 2019 - Nov 2020

Senior Director, Global Commercial, Tukysa, Ladiratuzumab Vedotin, Other Nmes

Bothell, Washington, Us

Feb 2018 - Dec 2019

Director Pipeline Commercial Strategy

Bothell, Washington, Us

Feb 2016 - Jan 2018

Associate Director, Adcetris Pathology Marketing, Pipeline Commercial Strategy

Bothell, Washington, Us

Feb 2014 - Jan 2016

Principle,, Pipeline Commercial Strategy & Adcetris Marketing

Bothell, Washington, Us

Apr 2010 - Jan 2014

Commercial Team Leader (Ctl) For Pertuzumab & T-Dm1

Commercial Pipeline Development

• Commercial leader on Core / Lifecycle Teams for pertuzumab (Perjeta™), trastuzumab emtansine (Kadcyla™) and three phase-1 assets• Partnered with Project Leadership, Development, Research & Market Planning to lead commercial strategy for NMEs including 3-year brand plans & the 1 year tactical plans• Led cross functional partners including corporate relations, advocacy, publications, market planning, & clinical development to achieve commercial goalso Development of preliminary product positioning & scientific statementso Thought leader development through advisory & other activities• Partnered with the Roche International Business Leader on alignment of global commercial strategy & other activities including brand name development & preliminary positioning• Managed $3 million budget for new product planning in anticipation for pertuzumab market launch• 2009 Marketing Excellence Award – Best Branding Campaigno Led the development & implementation of a scientific pipeline brand campaign for Genentech’s oncology NMEs to represent the pipeline at congress medical affairs booth with the goal to demonstrate leadership in oncology & company commitment to develop innovative products for unmet medical needs• 2008 Marketing Excellence Award – Best Branding Campaigno Development & execution of a disease education campaign, ResearchHERpathways.com, to outline key differentiation for a HER2-targeted agents under development• 2007 Marketing Excellence Award – Most Innovative Programo Created the Molecular Basis of Cancer program (MBoC) – a disease state program that educates physicians on fundamental & evolving concepts in cancer biology linked with biological pathways being targeted by pipeline agentso Co-led a cross functional team on execution of the MBoC Pilot program that resulted in access to physicians (N=262) who do not attend standard promotional dinner programs. MBoC program resulted in 2 FTEs and is still running at Genentech.

Nov 2006 - Mar 2010

Senior Product Manager, Avastin Marketing

South San Francisco, California, Us

Sep 2005 - Nov 2006

Clinical Oncology Specialist

Hercpetin Sales

• Developed strategic targeted, account specific business plans that drove the business from 90% to plan in 2003 to 115% to plan and moved the territory from to the top 15% in the nation• 2004 Essence of the Division Award for outstanding division teamwork.• 2004 Western Regional Kudos Award for business turn-around achievement.• 2004 Sales Achievement Award – 114.7% to plan; sales year: 109% to plan.

Aug 2003 - Aug 2005

Associate Marketing Manager

Commercial Development Group

Conducted a benchmarking & best-practices analysis of a competitor's anticipated blockbuster oncology product with a pre-launch marketplace awareness of 98%.

Jun 2002 - Sep 2002

Head Cancer Cytogenetic Technologist

Royal Columbian Hospital

Led a team that executed bone marrow cytogenetic laboratory procedures & performed chromosome analysis leading to formation of accurate diagnosis

Jan 1999 - Jan 2001

Clinical Cytogenetic Technologist

Cytogenetics Inc
Jan 1998 - Jan 2001

Clinical Cytogenetic Technologist Ii

Fred Hutchinson Cancer Research Center (Fhcrc)

Performed chromosome analysis & other technical laboratory clinical procedures & research.Executed assays & spearheaded analysis with a variety of oncology-related DNA probes for diagnosis & monitoring of patient relapse, remission, and chimera.

Jan 1997 - Jan 2001

Scientific Research Technician

University Of British
Jan 1993 - Jan 1995
8 education records

Robert Levak education

Certificate, Corporate Governance

Kellogg Executive Education

Mba, Health Care Management, Marketing

Northwestern University - Kellogg School Of Management

Post Baccalaureate Degree, Human Cytogenetics, Cancer Specialization

British Columbia Institute Of Technology

Education record

The University Of British Columbia

Medical Technology Post Baccalaureate

The University Of British Columbia

Bachelor Of Science, Biochemistry / Molecular Biology

British Columbia

Education record

Kellogg School Of Management

Master Of Business Administration, Marketing; Healthcare Management & Organizational Behavior

Northwestern University
FAQ

Frequently asked questions about Robert Levak

Quick answers generated from the profile data available on this page.

What company does Robert Levak work for?

Robert Levak works for Phoenix Molecular Designs.

What is Robert Levak's role at Phoenix Molecular Designs?

Robert Levak is listed as Business Owner at Phoenix Molecular Designs.

What is Robert Levak's email address?

AeroLeads has found 1 work email signal at @charter.net for Robert Levak at Phoenix Molecular Designs.

What is Robert Levak's phone number?

AeroLeads has found 5 phone signal(s) with area code 425, 206 for Robert Levak at Phoenix Molecular Designs.

Where is Robert Levak based?

Robert Levak is based in North Vancouver, British Columbia, Canada while working with Phoenix Molecular Designs.

What companies has Robert Levak worked for?

Robert Levak has worked for Levak Oncostrategy Consulting Sole Proprietorship, Phoenix Molecular Designs, Voxcell Bioinnovation, Zymeworks Inc., and Seagen.

How can I contact Robert Levak?

You can use AeroLeads to view verified contact signals for Robert Levak at Phoenix Molecular Designs, including work email, phone, and LinkedIn data when available.

What schools did Robert Levak attend?

Robert Levak holds Certificate, Corporate Governance from Kellogg Executive Education.

What skills is Robert Levak known for?

Robert Levak is listed with skills including Oncology, Clinical Trials, Clinical Development, Biotechnology, Cross Functional Team Leadership, Pharmaceutical Industry, Strategy, and Life Sciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.